# Grant A. McArthur

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/grant-a-mcarthur/

## Facts

| Field | Value |
| --- | --- |
| Citations | 80,925 |
| Field | Melanoma and MAPK Pathways |
| h-index | 103 |
| i10-index | 344 |
| Last Known Institution | The University of Melbourne |
| OpenAlex ID | https://openalex.org/A5048111860 |
| ORCID iD | https://orcid.org/0000-0001-8908-6071 |
| Works | 902 |

## Researcher papers

- [Oncogenic Signaling Pathways in The Cancer Genome Atlas](https://scholariq.org/papers/oncogenic-signaling-pathways-in-the-cancer-genome-atlas/)
- [<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors](https://scholariq.org/papers/i-ras-i-mutations-in-cutaneous-squamous-cell-carcinomas-in-patients-treated-with/)
- [Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study](https://scholariq.org/papers/combination-nivolumab-and-ipilimumab-or-nivolumab-alone-in-melanoma-brain/)
- [Phase II Study of the MEK1/MEK2 Inhibitor Trametinib in Patients With Metastatic <i>BRAF</i> -Mutant Cutaneous Melanoma Previously Treated With or Without a BRAF Inhibitor](https://scholariq.org/papers/phase-ii-study-of-the-mek1-mek2-inhibitor-trametinib-in-patients-with-metastatic/)
- [Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans](https://scholariq.org/papers/recombinant-ny-eso-1-protein-with-iscomatrix-adjuvant-induces-broad-integrated/)

## Researcher topics

- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

## Researcher university

- [The University of Melbourne](https://scholariq.org/institutions/the-university-of-melbourne/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.